Maternity Connect will replace contemporary paper-based maternity records with a connected digital person-centred pregnancy record and service. Maternity Connect will focus on improving connectivity amongst maternity relevant health systems to improve service efficiency and clinical outcomes. Maternity Connect will build on UK SME Rescon's (project lead) Lincus Maternity digital personal health record (PHR) and management tools to develop, test, iterate and evaluate four top level innovations to primarily decrease costs associated with delivering maternity care. Maternity Connect will co-create this service utilising the transformative work already completed with the Improving Me, Women's and Children's Services of the Cheshire and Merseyside Sustainability and Transformation Partnership. Maternity Connect has the following objectives: * To improve maternity health outcomes and decrease load on pressured health delivery resources using the Cheshire and Merseyside region (ImprovingMe) as the clinical development and delivery partner. * To develop a commercial go to market service delivery model utilising best in class innovations that will fulfil the clinical objectives above whilst providing a sustainable business model for the industrial and NHS partners The innovations are: 1.) The ongoing stakeholder led development of a best in class intelligent digital maternity personal health record (PHR), Lincus Maternity 2.) Connectivity, interoperability and integration * Transformation of Lincus Maternity into an NHS Digital defined Open Platform based on HL7 FHIR, SNOMED-CT, IHE-XDS and openEHR standards * Integration with GP, hospital, mental health, social care and community systems utilising AWS cloud services and leveraging the Global Digital Exemplar interoperability activities within Cheshire and Merseyside * Implementing the recently published NHS Digital Maternity PHR standards and utilising OpenEHR maternity archetypes for data handling * Developing maternity clinician portals including offline app capability 3.) Business Model: * Testing three different business delivery models including co-development of a new all-inclusive digital services business model fronted by Telefonica/O2 UK that brings together digital tools, devices and data packages for NHS and social care customers, directed in this instance at midwives delivering care. 4.) Evaluation: * Quantifying "digital dosage" utilising digital engagement from service users, service providers and communications that will allow for digital dosage/response calculations from a complete health economic approach * Integrating Care Quality Commission and Quality of Life surveys into Lincus Maternity and service delivery as part of routine clinical maternity practice. * Evaluating the impact of the three business models above being: standalone digital interventions; digital interventions with full training and support; and the integrated digital intervention, support, device and data service package.

"Improving Me Maternity (IMM) is a clinical and health economic assessment project of Rescon's CE marked Lincus software as a service connected Personal Health Record (PHR) management system for its application in the maternity, and postnatal marketplace. Rescon was commissioned by the NHS Women and Children's Improving Me Vanguard to develop Lincus Maternity as a digital maternity PHR that expectant mums could enter information into. The Improving Me Vanguard has been merged into the Cheshire and Merseyside Sustainable Transformation Partnership (STP) and supports over 30,000 births every year. The funding for the development of Lincus Maternity was justified to address poor maternity outcomes in the region along with the mismatch between tariffs and spend. Until the development of Lincus Maternity there was no tool available that would provide expectant mums with a CE marked and digitally held record that could be used to track and manage their health and wellbeing for better pregnancy and postnatal outcomes. Lincus Maternity developments and features are outlined below. * Lincus Maternity was co-developed utilising best practice guidelines, research and stakeholder engagement for tracking prenatal and postnatal signs, symptoms and events. * Lincus Maternity developments for expectant mums have included signposting to educational content, nutrition and activity management, transition of care tools (health passport), and video consultation. * Lincus Maternity allows clinical access to the woman's PHR as a unified collation of all pregnancy related information. It has alert functionality which was an especially important feature for midwives in the co-development sessions. * Lincus Maternity allows administration access so management can review clinical activities and outcomes using IMM's data aggregation and analysis tool that is already native to the Lincus platform. Though Lincus Maternity is now officially live having completed information and clinical governance requirements, iterative technical development continues with planned full release in April 2019\. We have completed early discussions with senior clinical teams and NICE about the best way to assess Lincus Maternity however are lacking the resources to prepare for and complete a full health economic assessment that would provide the evidence to have Lincus Maternity commissioned across the UK and beyond. IMM will provide Rescon with the resources they need to build in women, family, commissioner, clinician, NHS, NICE and Royal College informed evaluation tools and conduct a controlled trial with the Wirral Clinical Commissioning Group. This will allow the team to gather the evidence that will support future commissioning and sustainability of Lincus Maternity."

"Improving Me Maternity (IMM) is a clinical and health economic assessment project of Rescon's CE marked Lincus software as a service product for its application in the maternity, and postnatal marketplace. Rescon was commissioned by the NHS Women and Children's Improving Me Vanguard to develop Lincus Maternity as a digital maternity person held record (PHR) that expectant mums could enter information into. The Improving Me Vanguard is due to be merged into the Merseyside and Cheshire Sustainable Transformation Partnership and supports over 30,000 births every year. The funding for the development of Lincus Maternity was justified to address mental health issues, overweight and obese mum's, smoking and diabetes during pregnancy. The above pregnancy associated comorbidities cost the region over £80 million in direct costs per year. Until the development of Lincus Maternity there was no tool available that would provide expectant mums with a CE marked and digitally held record that they could track and manage their health and wellbeing for better pregnancy and postnatal outcomes. Lincus Maternity developments and features are outlined below. * Lincus Maternity was codeveloped utilising best practice guidelines, research and stakeholder engagement for tracking prenatal and postnatal signs, symptoms and events. * Lincus Maternity developments for expectant mums have included signposting to educational content , nutrition and activity management, transition of care tools (health passport), and video consultation. * Lincus Maternity allows clinical access to the women's PHR with alert functionality which feedback as especially important for midwives in the cedevelopment sessions. * Lincus Maternity allows administration access so management can review clinical activities and outcomes using IMM's data aggregation and analysis tool that is already native to the Lincus platform. Though Lincus Maternity is now officially live having completed information and clinical governance requirements the formal and structured rollout of IMM is not expected until later summer of 2018\. We have completed early discussions with senior clinical teams and NICE about the best way to assess Lincus Maternity however are lacking the resources to prepare for and complete a full health economic assessment that would provide the evidence to have Lincus Maternity commissioned across the UK and beyond. IMM will provide Rescon with the resources they need to formally engage with NICE, senior clinicians and the Manchester University Centre for Health Economics to formulate a comprehensive evaluation strategy and plan. This will allow the team to gather the evidence that will support future commissioning of Lincus Maternity."

Almost 1 in 1,000 babies are born with congenital heart disease every year. In England, this results in 3,600 surgical procedures, with over 500 performed at Alder Hey Children’s Hospital. Following surgery, delayed discharge is common and costly, reducing capacity for new admissions and impacting children and their families. We will stimulate high-quality, human-centred design activities for the development of a novel telehealth service solution (Alder Hey @Home) to support early discharge in collaboration with Alder Hey Children’s Hospital clinicians, administrators, patients and their families. Stakeholder-led design and collaboration will feature, enabling all stakeholders to identify what is needed from the Alder Hey @Home solution. Multimedia designs and technology combinations will be used to validate user experience and lead to further iterative design. Whilst this project will focus on the design of Alder Hey @Home specifically for children’s cardiac surgery, it will be readily adaptable for the wider inpatient service. The Alder Hey @Home solution will expand the reach of the hospital team into the community, allowing children to leave hospital earlier and recover safely whilst enabling close communication with specialist hospital staff.

The Diabetes Digital Coach Test Bed will provide the infrastructure for mobile health self-management tools (wearable sensors and supporting software) to take advantage of new developments in connecting monitoring devices (Internet of Things) so people with Type 1 or Type 2 diabetes 'do the right thing at the right time' to self-manage their condition. An additional benefit will be more timely & appropriate interventions from peers, healthcare professionals, carers and social networks. Our collective vision is to 'Enable every citizen to self-care in their own way to the benefit of their health, both physical and mental' . We will also address how the data generated through the tools can be owned and managed by people with diabetes through a personal firewall for individuals to give consent and access to share this data with other systems such as analytics engines and healthcare practitioner portals (eg or local Connecting Care platform) We subsequently intend to aggregate data, information and knowledge to gain a real time population wide view of the health status of people with diabetes to nudge and promote behaviours to improve health.

Profile Wizard, pWizard, will develop a revolutionary software technology that will provide an accessible and rich User Experience (UX) for individuals managing their own health, applied to an officially recognised health and wellbeing product, Lincus. pWizard will be led by SME Rescon along with exceptional technologists from Liverpool John Moores and Liverpool Universities, Citrus Suite and Affect_In. pWizard will assist individuals so they can easily register and log in to Lincus. It will tailor an individual’s UX based on preference and personality tests that will be fun to complete. pWizard will allow individuals to choose whether to have their emotions and vital signs recorded whilst using the platform using a state of the art video capture technologies. Together all the information will be taken, including Lincus wellbeing data to enrich the UX, predict negative events before they happen, and recommend interventions to get people on the right path by using best in class machine learning technologies. The outputs may also be used by social and health care providers to assist them in decisions so they can provide the best possible care for the individuals they support.

Rescon’s wearable acoustics Proof of Market project is an investigation into the commercial feasibility of our wearable acoustics technology. This builds on a successful TSB funded technical feasibility project that investigated the development of a wearable microphone system that detects sounds associated with health and wellbeing. We developed wearable hardware and analytics technologies that proved the feasibility of microphones, both wearable and ambient in detection of coughing, choking and heavy breathing. Rescon, in collaboration with Milner consultants, are going to profile the market. Firstly we will research target sectors including key respiratory and cardiac diseases, future trends in these diseases, long-term sector trends, and other important areas that emerge from the research. We will investigate the best technology format for market introduction. Secondly we are going to profile target regions looking at barriers to entry. These profiles will include country demographics and regional factors affecting our technology take-up. Thirdly we will profile key competitors, with a comparative summary of functionality. Competitor strategies will be identified based on current and future portfolio mixes and regional focus. Competitor pricing for similar products and services will be collected where possible. Milner will develop a bespoke Excelbased market model for Rescon. Rescon will complete IP searches to clarify position and potential for submission of patents based on previous work. Rescon will also forecast costs for project stages including building of prototypes and taking the acoustic sensor technology to market. Collaboratively, a final proof of market report will be written summarising the market opportunity over the next twenty years. The market will be described in volume and value terms and split by sector and by region. This will be used to develop strategic options and recommendations covering suggested routes to market and brand positioning.

Rescon’s glutathione sensor Proof of Market project is an investigation into the commercial feasibility of our anti-oxidant sensor technology. This follows on from the early development of our anti-oxidant sensor technology that can measure oxidative stress and ability to combat it. Measuring anti-oxidants is important as they are a key indicator of health status and diseases such as Alzheimer’s, diabetes and cancer. The end result of this project is to assess the feasibility of developing this technology for use in laboratory, clinical settings and for selfmanagement at home. Traditional tests are expensive, time-consuming, and require blood to be drawn. Rescon’s technology is portable and can be used by a patient, saving the healthcare system time and money. This technology also might be applied to animal health, the food industry, and crop production markets. In collaboration with Milner consultants, Rescon will profile the market including key diseases, future trends in diseases, long-term sector trends, and any other important areas that emerge. We will interview key stakeholders to investigate the best format our technology should be in to solve their problems and for optimal market uptake. We will profile international markets, looking at demographics and barriers to uptake. We will also profile our competitors, with a comparative summary of functionality, pricing for similar products, and strategy. To build upon this profile Rescon will complete IP searches to clarify market position and potential for submission of additional patents, as well as forecasting costs for project stages including manufacturing and taking the technology to market. Milner will consolidate this research to develop a market model for Rescon. A final proof of market report will be written summarising the market opportunity over the next 20 years. This will be used to develop strategy and recommendations covering suggested routes to market and brand positioning.

"One Precious Life" is an ambitious project that will treat individuals in the UK with Long Term Conditions, such as diabetes, heart disease, dementia, stroke-survivors, asthma and arthritis, as we would high performance athletes. Rescon, a UK human performance company, has teamed up with Going For Independence, a UK social enterprise focused on empowering individuals to become independent, to deliver One Precious Life. The team are going to actively recruit two individuals with a human performance background and pair them with two individuals from a social care or health background. They are going to house these four coaches together for three months where they will learn about how to apply the principles of high performance athlete training and service to those with Long Term Conditions. They will learn off each other, as well as from the expertise of Rescon and Going For Independence. They will also develop a new competition, designed to be inclusive, fun, active and a great spectator sport, based off the principles of popular sports and paralympic inclusivity. Evaluation and monitoring technologies will be developed, as elite athletes would use, but specifically tailored to those with long term conditions, as appropriate. After the development and training phase the coaches, and their support team, will go into hospitals, and recruit particpants in the program who have both the motivation to be involved and long term conditions. These individuals will be followed up in their own homes where they will be trained up with no attention to detail spared. They will be trained and educated in activity, nutrition, form, function, recovery, managing their conditions, social life, sexual health, and how to access all the information they may need to optimse their day to day performance. A specific target in this program is the participation of all "athletes" in the end of program tournament. Our athletes will compete in an arena in this first of its kind competition where success is not just judged on points scored. Equally weighted to points are team work, being sporting and style. By the end of the program we will have taken 28 individuals, with long term conditions, and given them new hope, an improved body, mind and spirit whilst giving the four coaches a new career in high performance delivery to those who most need it. The pilot of One Precious Life, will build up the resource, knowledge and evidence for delivering this approach to the UK population at scale. One Previous Life will not only save a generation that are chained by a system that does not address individuals with Long Term Conditions as valuable, it will also increase employment and booster new industry and the UK economy. One Precious Life is part of the Long Term Care Revolution. Together with the other pilots that are part of the Long Term Care Revolution we will transform the face of the Health and Social Care industry in the UK, providing a better present and future for us all.

Awaiting Public Project Summary

Awaiting Public Project Summary

The wearable acoustics project is investigating the feasibility of developing a low profile wearable microphone system that detects sounds associated with health and wellbeing. If successful this technology will allow people to be monitoried for heart and lung conditions at home reducing the burden on hospitals, clinics and the healthcare system. The technology will also be able to be used for monitoring the performance of athletes and the military. It is also expected that the acoustic system will be able to be used for security identification and monitoring purposes. If this technology is shown to be feasible then it will be developed to address market needs in the healthcare, human performance, veterinary and security sectors bringing revenue into the UK and creating new market opportunities for UK industry.